Medical devices, healthcare technology and the business of care
PMA approval · P060011

C-FLEX MODEL 570C INTRAOCULAR LENS (IOL)

Rayner Intraocular Lenses , Ltd. · Decision date May 3, 2007

MEDTECHLEDGER EXPLANATIONP060011

What did the FDA approve?

The FDA database entry records an original PMA approval for the C-FLEX Model 570C intraocular lens from Rayner Intraocular Lenses, Ltd. The stated purpose is primary implantation for visual correction of aphakia in adults after cataract removal by phacoemulsification, with the lens intended for placement in the capsular bag.

The entry does not include a supplement type or supplement reason, so no changed item or modification to a prior approval is described. The source statement reports the approved indication and intended placement but does not provide clinical data, safety findings, or effectiveness conclusions.

FDA approval order statement

APPROVAL FOR THE C-FLEX MODEL 570C INTRAOCULAR LENS (IOL). THE DEVICE IS INDICATED FOR PRIMARY IMPLANTATION FOR THE VISUAL CORRECTION OF APHAKIA IN ADULTS IN WHOM A CATARACTOUS LENS HAS BEEN REMOVED BY PHACOEMULSIFICA-TION. THE LENS IS INTENDED TO BE PLACE IN THE CAPSULAR BAG.
Regulatory pathway
Original PMA
Clinical specialty
Ophthalmic
Decision date
May 3, 2007

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P060011
Regulatory pathway
Premarket approval application
Product code
HQL
Decision code
APPR
Decision date
May 3, 2007
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: intraocular lens.

Product code
HQL
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P060011 received

    Application receipt date recorded by FDA.

  2. P060011 · FDA decision

    APPR

  3. P060011/S045 · Related supplement

    RayOne Galaxy; Model RAO605G, RayOne Galaxy Toric; Model RAO615X

Timeline entries are records held by MedtechLedger for P060011. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P060011

Product / regulatory recordCompanyPathwayDecision dateSource
Rayner Intraocular Lenses , Ltd.PMA supplementSep 24, 2026FDA

Explore the linked device profile

Other records with product code HQL

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Rayner Intraocular Lenses , Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1-2 Sackville Trading Estate,, Sackville Rd., Hove, E. Sussex, BN3 7AN

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records